Obenshain Andrew 的 Form 4 申報
bluebird bio, Inc.（BLUE），2022/1/12 申報
- 申報編號
- 0001562180-22-000441
- 申報時間
- 2022/1/12
- 交易日
- 2022/1/10-1/11
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $7.36 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Obenshain AndrewCIK 0001839697 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The range in prices for the transaction reported on this line was $8.96 to $9.36. The average weighted price was $9.2445. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The range in prices for the transaction reported on this line was $9.385 to $9.42. The average weighted price was $9.4022. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The range in prices for the transaction reported on this line was $9.48 to $9.83. The average weighted price was $9.6426. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。